Investor Relations

Webcasts and Presentations

Webcasts

Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2025 Financial Results

April 14, 2025

Presentations

Neurocrine Biosciences Conference Call and Webcast of Fourth Quarter and Year-End 2024 Financial Results

Feb. 6, 2025

Download

Go To Webcasts & Presentations

Latest News Releases

04/30/25

Neurocrine Biosciences Initiates Phase 3 Registrational Program for NBI-1117568 as Potential Treatment for Adults with Schizophrenia

04/24/25

Neurocrine Biosciences Publishes Analysis Showing Long-Term Efficacy and a Consistent Safety Profile of INGREZZA® (valbenazine) Capsules in Older Adults with Tardive Dyskinesia in The Journal of Clinical Psychiatry

View All News Releases

Q3 Earnings

Press Release Webcast Presentation

Latest Filings

Filing Date	Form	Description	Filing Group	View
04/28/25	SCHEDULE 13G/A	SCHEDULE 13G/A - Description	Other	View the html document View the rtf document View the pdf document View the xls document
04/09/25	ARS	An annual report to security holders	Annual Filings	View the html document View the rtf document View the pdf document
04/09/25	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	Proxy Filings	View the html document View the rtf document View the pdf document View the xls document View the ixbrl document